Scyllo-Inositol Pharmaceutical Grade from Japan
Scyllo-inositol is an inositol stereoisomer researched for Alzheimer's treatment, classified under HTS 2906.13.10.00 as a pure cyclic alcohol. It meets pharmacopeia standards for use in clinical trials and drug development.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include USP/EP certificate of analysis proving ≥98% purity to maintain Chapter 29 classification
• Declare intended use as bulk API; finished dosage forms reclassify to Chapter 30
• Monitor for DEA scheduling if combined with other actives, though pure inositols are unregulated